Brevenal, a Marine Natural Product, is Anti-Inflammatory and an Immunomodulator of Macrophage and Lung Epithelial Cells
Chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma, are some of the leading causes of illness and fatalities worldwide. The search for novel treatments led to the exploration of marine natural products as drug candidates to combat the de...
Main Authors: | Devon M. Keeler, Meghan K. Grandal, Jennifer R. McCall |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/17/3/184 |
Similar Items
-
Structure Activity Relationship of Brevenal Hydrazide Derivatives
by: Allan Goodman, et al.
Published: (2014-03-01) -
Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease
by: Raquel Centeio, et al.
Published: (2021-07-01) -
Epithelial Sodium and Chloride Channels and Asthma
by: Wen Wang, et al.
Published: (2015-01-01) -
Macrophage Polarization in Leishmaniasis: Broadening Horizons
by: Fernanda Tomiotto-Pellissier, et al.
Published: (2018-10-01) -
Effects of second hand smoke on airway secretion and mucociliary clearance
by: Yanyan eLiu, et al.
Published: (2012-08-01)